Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
GaBI Journal is Scopus-indexed (Q3, CiteScore 0.7), WoS ESCI. Published by Pro Pharma Communications International.
Checked against the index lists dated .
ISSN 2033-6403Verify ISSN ↗2033-6772Verify ISSN ↗
Publisher: Pro Pharma Communications International
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacy | 34 / 52 | 35th | Q3 |
| Drug Guides | 7 / 10 | 35th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–2025, best quartile Q3, CiteScore 0.7.
GaBI Journal is Q3 in Pharmacy (rank 34 of 52) and Q3 in Drug Guides (rank 7 of 10), by CiteScore 2025.
GaBI Journal is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.7, which places it in quartile Q3 at the 35th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.224, quartile Q1, with an H-index of 16.
GaBI Journal is published by Pro Pharma Communications International. Its print ISSN is 2033-6403 and its online ISSN is 2033-6772.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
GaBI Journal has an h-index of 25 and a 2-year mean of 0.63 citations per paper (OpenAlex). Its Scopus CiteScore is 0.7, quartile Q3. On 2-year citations it ranks #29 of 50 Scopus journals in Pharmacy.
GaBI Journal published 19 papers in 2025; its busiest recent year was 2017 with 47. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.